Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7

Abstract Primary human hepatocytes are necessary to evaluate cytotoxicity, drug metabolism, and drug–drug interactions for candidate compounds in early-phase drug discovery and development. However, these analyses are often hampered by limited resources and functional or genetic variation among lots...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Takafumi Ueyama, Saori Tsuji, Takemi Sugiyama, Masako Tada
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/586c1d68c8994fc387df6a32a7dc4378
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:586c1d68c8994fc387df6a32a7dc4378
record_format dspace
spelling oai:doaj.org-article:586c1d68c8994fc387df6a32a7dc43782021-12-02T16:07:44ZFluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A710.1038/s41598-017-03146-52045-2322https://doaj.org/article/586c1d68c8994fc387df6a32a7dc43782017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03146-5https://doaj.org/toc/2045-2322Abstract Primary human hepatocytes are necessary to evaluate cytotoxicity, drug metabolism, and drug–drug interactions for candidate compounds in early-phase drug discovery and development. However, these analyses are often hampered by limited resources and functional or genetic variation among lots. HepaRG human hepatocellular carcinoma cells can differentiate into mature hepatocyte-like cells (HepLCs) that possess similar metabolic activity to human hepatocytes. We previously established transgenic HepaRG cells carrying a dual reporter that express red fluorescent protein (RFP) under the transcriptional regulation of CYP3A7 in the hepatoblast-like cell state and enhanced green fluorescent protein (EGFP) under the transcriptional regulation of CYP3A4 following HepLC differentiation. In this study, we successfully isolated a subclone of transgenic CYP3A4G/7R HepaRG cells with an improved HepLC differentiation potency. Midazolam metabolism by CYP3A4 in these HepLCs was comparable to that in wild-type HepLCs. The EGFP fluorescence intensity was greatly induced by rifampicin (RIF) treatment. There was a strong correlation between fluorometric and metabolic analyses. The fold change in EGFP-positive cells was comparable to those in the CYP3A4 mRNA level and luminescence of proluciferin metabolites. RIF treatment and cell proliferation increased the RFP-positive cell number. Thus, CYP3A4G/7R HepLCs provide a real-time, multiwell-based system to co-evaluate CYP3A4 induction and hepatic regeneration.Takafumi UeyamaSaori TsujiTakemi SugiyamaMasako TadaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Takafumi Ueyama
Saori Tsuji
Takemi Sugiyama
Masako Tada
Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7
description Abstract Primary human hepatocytes are necessary to evaluate cytotoxicity, drug metabolism, and drug–drug interactions for candidate compounds in early-phase drug discovery and development. However, these analyses are often hampered by limited resources and functional or genetic variation among lots. HepaRG human hepatocellular carcinoma cells can differentiate into mature hepatocyte-like cells (HepLCs) that possess similar metabolic activity to human hepatocytes. We previously established transgenic HepaRG cells carrying a dual reporter that express red fluorescent protein (RFP) under the transcriptional regulation of CYP3A7 in the hepatoblast-like cell state and enhanced green fluorescent protein (EGFP) under the transcriptional regulation of CYP3A4 following HepLC differentiation. In this study, we successfully isolated a subclone of transgenic CYP3A4G/7R HepaRG cells with an improved HepLC differentiation potency. Midazolam metabolism by CYP3A4 in these HepLCs was comparable to that in wild-type HepLCs. The EGFP fluorescence intensity was greatly induced by rifampicin (RIF) treatment. There was a strong correlation between fluorometric and metabolic analyses. The fold change in EGFP-positive cells was comparable to those in the CYP3A4 mRNA level and luminescence of proluciferin metabolites. RIF treatment and cell proliferation increased the RFP-positive cell number. Thus, CYP3A4G/7R HepLCs provide a real-time, multiwell-based system to co-evaluate CYP3A4 induction and hepatic regeneration.
format article
author Takafumi Ueyama
Saori Tsuji
Takemi Sugiyama
Masako Tada
author_facet Takafumi Ueyama
Saori Tsuji
Takemi Sugiyama
Masako Tada
author_sort Takafumi Ueyama
title Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7
title_short Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7
title_full Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7
title_fullStr Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7
title_full_unstemmed Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7
title_sort fluorometric evaluation of cyp3a4 expression using improved transgenic heparg cells carrying a dual-colour reporter for cyp3a4 and cyp3a7
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/586c1d68c8994fc387df6a32a7dc4378
work_keys_str_mv AT takafumiueyama fluorometricevaluationofcyp3a4expressionusingimprovedtransgenichepargcellscarryingadualcolourreporterforcyp3a4andcyp3a7
AT saoritsuji fluorometricevaluationofcyp3a4expressionusingimprovedtransgenichepargcellscarryingadualcolourreporterforcyp3a4andcyp3a7
AT takemisugiyama fluorometricevaluationofcyp3a4expressionusingimprovedtransgenichepargcellscarryingadualcolourreporterforcyp3a4andcyp3a7
AT masakotada fluorometricevaluationofcyp3a4expressionusingimprovedtransgenichepargcellscarryingadualcolourreporterforcyp3a4andcyp3a7
_version_ 1718384717316751360